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Nicotine, the primary addictive substance in to-
bacco, induces profound behavioral responses
in mammals, but the underlying genetic mech-
anisms are not well understood. Here we de-
velop a C. elegans model of nicotine-depen-
dent behavior. We show that worms exhibit
behavioral responses to nicotine that parallel
those observed in mammals, including acute
response, tolerance, withdrawal, and sensitiza-
tion. These nicotine responses require nicotinic
acetylcholine receptor (nAChR) family genes
that are known to mediate nicotine depen-
dence in mammals, suggesting functional con-
servation of nAChRs in nicotine responses. Im-
portantly, we find that mutant worms lacking
TRPC (transient receptor potential canonical)
channels are defective in their response to nic-
otine and that such a defect can be rescued
by a human TRPC channel, revealing an unex-
pected role for TRPC channels in regulating
nicotine-dependent behavior. Thus, C. elegans
can be used to characterize known genes as
well as to identify new genes regulating nicotine
responses.
INTRODUCTION
Nicotine dependence is a worldwide health problem and
represents the leading preventable cause of death in in-
dustrialized countries (Champtiaux and Changeux, 2004;
Laviolette and van der Kooy, 2004). The primary molecular
target of nicotine is nicotinic acetylcholine receptors
(nAChRs), a family of pentameric calcium-permeable cat-
ion channels (Champtiaux and Changeux, 2004). In mam-
mals, nicotine binds to nAChRs in the ventral tegmental
area, leading to stimulation of the mesolimbic dopaminesystem (Laviolette and van der Kooy, 2004). While much
is known about the role of nicotine in directly modulating
the function of nAChRs, the genetic mechanisms bywhich
such modulation leads to prolonged behavioral and neu-
rological changes are poorly understood.
Due to their simple nervous system and amenability to
genetic manipulation, invertebrate organisms such as
C. elegans andDrosophila have beenwidely utilized as ge-
neticmodels to study various phenomena in neurobiology,
including substance dependence. For example, recent
studies in Drosophila have provided new insights into the
mechanismsof alcohol tolerance/intoxication and cocaine
sensitivity, and work in C. elegans has identified novel
players involved in alcohol intoxication (Andretic et al.,
1999; Bainton et al., 2005; Davies et al., 2003; Scholz
et al., 2005). The C. elegans genome encodes 28 nAChR
genes, many of which have been shown to form functional
nAChRs in heterologous systems (Jones and Sattelle,
2004). While the role of nicotine in regulating the activity
of muscle cells (e.g., egg-laying and body-wall muscles)
has beenwell characterized (Gottschalk et al., 2005; Lewis
et al., 1980; Waggoner et al., 2000), the effects of nicotine
on the function of the nervous system,whichmediates nic-
otinedependence in vertebrates, havenot beenevaluated.
TRP (transient receptor potential) channels represent
a superfamily of cation channels conserved from worms
to humans and comprise seven subfamilies (TRPC,
TRPV, TRPM, TRPN, TRPA, TRPP, and TRPML) (Montell,
2005; Ramsey et al., 2006). The founding members of the
TRP superfamily are the TRPC (TRP canonical) channels,
which can be activated following the stimulation of phos-
pholipase C and/or depletion of internal calcium stores
(Montell, 2005). However, the precise mechanisms lead-
ing to TRPC activation remain unclear and somewhat con-
troversial. Studies in cell culture systems have implicated
TRPCs in a wide variety of physiological processes in
mammals ranging from muscle relaxation/contraction,
fluid secretion, and growth-cone guidance and morphol-
ogy to acrosome reaction (Montell, 2005; Ramsey et al.,
2006). Nevertheless, the genetic evidence supporting
such functions is limited.Cell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc. 621
Figure 1. C. elegansResponds to Acute Nicotine Treatment, Develops Tolerance to Chronic Nicotine Exposure, and Exhibits With-
drawal Symptoms upon Nicotine Cessation
(A) The locomotion activity (centroid speed) of naive animals (N2) versus time on nicotine-free plates. Naive wild-type animals picked to a fresh plate
moved at high speed initially because of the mechanical stimuli resulting from picking. Speed during the first 1.5 min is not shown due to high
variations. See Figure S2D for longer time points. Shown is a sample trace averaged from 10 animals.
(B) Acute nicotine response. Assays were performed as in (A) except on plates containing 1.5 mM nicotine.
(C) Worms become adapted to nicotine after chronic nicotine treatment. Worms treated with 1.5 mM nicotine overnight were analyzed for their
response to nicotine on nicotine plates.
(D) Nicotine cessation induces withdrawal responses. Worms treated with 1.5 mM nicotine for 16 hr were moved to nicotine-free plates.
(E) Nicotine responses in naive animals are dose dependent. The locomotion-stimulation index was used to quantify nicotine effects as described in
the Supplemental Data. In this and all other figures, unless otherwise noted, error bars represent SD.
(F) The time course of nicotine tolerance (adaptation). Worms were treated with 1.5 mM nicotine for various lengths of time, and their response to
nicotine was subsequently analyzed on plates containing the same concentration of nicotine. nR 10.In the current study, we developed a C. elegans model
of nicotine-dependent behavior. We show that worms dis-
play acute and chronic behavioral responses to nicotine
that parallel those observed in mammals. These re-
sponses require nAChRs that are known to be critical for
nicotine dependence in mammals. Significantly, we have
found that TRPC channels regulate nicotine-dependent
behavior by functionally modulating nicotine-induced
cellular responses in the locomotion circuitry. Our results
suggest that C. elegans can be used as a genetic model
for identifying and characterizing neuronal genes regulat-
ing nicotine responses.
RESULTS
Worms Respond to Acute Nicotine Exposure,
Develop Tolerance to Chronic Nicotine Treatment,
and Exhibit Withdrawal Responses upon
Nicotine Cessation
In rodent models, nicotine stimulates locomotor activity in
naive animals, though it initially induces transient hypoac-
tivity (Dwoskin et al., 1999). Chronic nicotine treatment622 Cell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc.adapts animals to nicotine (Dwoskin et al., 1999; Lavio-
lette and van der Kooy, 2004). In addition, nicotine cessa-
tion evokes withdrawal symptoms (Kenny and Markou,
2001). To quantify the effects of nicotine on worm locomo-
tion, we used a worm tracking system that records worm
locomotion and reports its activity, such as locomotion
velocity, in real time (Li et al., 2006).
We first examined the locomotion behavior of naive an-
imals. After being transferred to a new environment (i.e.,
a fresh plate with bacteria), the animals exhibited a contin-
uous decay in locomotion speed until reaching a relatively
steady state (Figure 1A; see also Figure S2D in the Supple-
mental Data available with this article online), consistent
with previous observations (Zhao et al., 2003). However,
when assayed on plates containing nicotine, the animals
displayed a distinct locomotion behavior: After a brief
rapid decay in locomotion speed, the animals began to
gradually speed up their locomotion (Figure 1B). We
named this phenomenon ‘‘locomotion-stimulation.’’ The
locomotion-stimulation phase, which was not seen in na-
ive animals, became evident starting at 4 min after the
acute nicotine incubation and perdured until the speed
Figure 2. Repeated Intermittent Nicotine Treatments Sensitize Worms’ Response to Nicotine
(A) Lack of significant locomotion-stimulation in presensitized animals. Naı¨ve wild-type animals were assayed on plates containing 500 nM nicotine.
Shown is a sample trace averaged from ten animals.
(B) Behavioral sensitization by repeated intermittent nicotine treatments. Wild-type worms were treated with 500 nM nicotine for 20 min up to three
times. Between each treatment, worms were left on nicotine-free plates for 75 min. Two hours after the third nicotine treatment, their response to
nicotine was assayed on plates containing 500 nM nicotine.
(C) Behavioral sensitization by repeated intermittent nicotine treatments. If no nicotine was included during the treatment, no behavioral sensitization
was observed. Control represents data from naive worms in response to a higher concentration of nicotine (5 mM). *p < 0.05 (ANOVA with Kruskal-
Wallis H test).
(D) Continuous nicotine treatment fails to induce behavioral sensitization. Worms were treated with nicotine as in (B), except that the duration of the
interval between each treatment varied as indicated. *p < 0.03 (ANOVA with Kruskal-Wallis H test).
(E) The time course of nicotine sensitization. The protocol was the same as in (B), except that after the last treatment, worms were incubated on
nicotine-free plates for various lengths of time as indicated. Subsequently, they were analyzed for response to 500 nM nicotine. *p < 0.03 (ANOVA
with Kruskal-Wallis H test). nR 10.plateaued (Figure 1B). Such a response to nicotine was
dose dependent and peaked at around 1.5 mM (Figure 1E).
Interestingly, the nicotine concentration in human blood
peaks at 500 nM after consumption of one cigarette
(Pidoplichko et al., 1997).
We next tested the long-term effects of nicotine on loco-
motion and found that, after chronic nicotine treatment,
worms developed tolerance to nicotine in a time-depen-
dent manner (Figures 1C and 1F; Figure S2E). As a result,
these nicotine-adapted animals behaved similarly to
naive animals on nicotine-free plates, demonstrating that
chronic nicotine treatment elicits tolerance (adaptation)
in C. elegans (Figures 1C and 1F).
To test the effects of nicotine withdrawal, we moved the
animals that were chronically treated (>16 hr) with nicotine
to nicotine-free plates. In response to such nicotine ces-
sation, these nicotine-adapted animals began to increase
their locomotion speed at4min after nicotine withdrawal
and displayed a locomotion-stimulation phase similar to
that observed in naive animals responding to acute nico-
tine exposure (Figure 1D). This suggests that these nico-tine-adapted animals became dependent on nicotine for
their naive-like behavior on nicotine plates (Figure 1D).
These results indicate that nicotine cessation can induce
withdrawal responses in C. elegans.
Worms Can Be Behaviorally Sensitized to Nicotine
by Repeated Intermittent Nicotine Challenges
In vertebrates, repeated intermittent administrations of
nicotine can sensitize an animal’s response to nicotine,
a process believed to be critical for the development of
nicotine dependence (Dwoskin et al., 1999; Laviolette
and van der Kooy, 2004). To test whether worms can be
sensitized to nicotine, we treated naive animals for 20
min with a lower concentration of nicotine that did not
induce significant locomotion-stimulation in naive ani-
mals (Figure 2A). Subsequently, we moved these nico-
tine-treated animals to nicotine-free plates for a recovery
period before subjecting them to another round of treat-
ment. After three doses of such treatment, the same
low concentration of nicotine then evoked robustCell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc. 623
Figure 3. Nicotine-Dependent Behavior Requires Nicotinic Receptors
(A) Suppression of behavioral responses to nicotine by DHbE (20 mM). DHbE did not significantly reduce the basal locomotion rate (Figure S2C).
*p < 0.005 (Mann-Whitney U test).
(B) DHbE induces withdrawal symptoms in nicotine-adapted animals. Nicotine-adapted animals (16 hr treatment) were moved to plates containing
both DHbE and nicotine. Control represents data from nicotine-adapted animals assayed on nicotine-containing plates (no withdrawal treatment).
*p < 0.03 (ANOVA with Kruskal-Wallis H test).
(C) Dendrogram of C. elegans nAChRs. Mouse a4, b2, and a7 were included. The nAChR genes that do not have mutants available are in light gray.
(D) No significant acute response to nicotine is detected in four nAChR mutants. See Experimental Procedures for allele names. *p < 0.001 (ANOVA
with Kruskal-Wallis H test).
(E) Mouse a4b2 nAChR can restore the acute response to nicotine in acr-16(ok789) mutant animals. *p < 0.02 (ANOVA with Kruskal-Wallis H test).
nR 10.locomotion-stimulation in these animals, indicating that
worms can be sensitized to nicotine (Figures 2B and 2C).
It could be argued that the observed nicotine sensitiza-
tion might be caused by the accumulation of nicotine in
worms. Two observations argue against this possibility.
First, nicotine sensitization can only be seen with intermit-
tent nicotine treatments (Figure 2D), whereas continuous
nicotine treatments, which would presumably result in
the accumulation of more nicotine, failed to induce sensi-
tization (Figure 2D). Second, the sensitization effect did
not peak until the treated animals rested on nicotine-free
plates for 1 hr after the last dose of nicotine treatment
(Figure 2E), providing further evidence that the observed
sensitization effect was not simply due to the accumula-
tion of nicotine.
Taken together, our data show that worms exhibit nico-
tine-dependent behavior: They respond to acute nicotine
treatment, develop tolerance to chronic nicotine expo-
sure, display withdrawal symptoms upon nicotine cessa-624 Cell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc.tion, and become sensitized to nicotine after repetitive nic-
otine challenges. These behavioral responses to nicotine
seem to parallel those observed in vertebrates.
Nicotine-Dependent Behavior Requires nAChRs
Having developed a model for characterizing nicotine-
dependent behavior, we then asked what genes might un-
derlie this behavior in C. elegans. In vertebrates, the psy-
chostimulatory effects of nicotine require nAChRs, the
molecular target of nicotine (Champtiaux and Changeux,
2004). As a first step to test whether these receptors are
also required for nicotine responses in C. elegans, we
challenged worms with DHbE, a nAChR competitive an-
tagonist (Champtiaux and Changeux, 2004). This antago-
nist suppressed the acute nicotine response as well as
nicotine sensitization in wild-type animals (Figure 3A). In
vertebrates, nAChR antagonists can mimic the effects of
nicotine cessation by inducing withdrawal-like symptoms
in nicotine-treated animals in the presence of nicotine
(Kenny and Markou, 2001). We also observed a similar
DHbE-induced phenomenon in C. elegans (Figure 3B).
These results provide strong pharmacological evidence
that nicotine-dependent behavior in C. elegans requires
nAChRs.
We next sought to provide genetic evidence for the re-
quirement of nAChRs for nicotine responses inC. elegans.
The C. elegans genome encodes 28 nAChRs (Jones and
Sattelle, 2004), most of which have mutants available
(Figure 3C). We screened these mutants and found that
acr-15 and acr-16 mutant worms lacked response to
acute nicotine treatment (Figure 3D), though both mutants
were otherwise superficially wild-type (Francis et al., 2005;
Touroutine et al., 2005; Figure S1). As a result of this de-
fect, the mutant worms were also defective in nicotine
withdrawal and sensitization (Figures S2A and S2B).
Thus, ACR-15 and ACR-16 are required for nicotine-de-
pendent behavior. unc-63 and unc-38 mutants were also
defective in response to nicotine (Figure 3D); however, it
remains possible that such a deficit might result from
a nonspecific defect in locomotion because bothmutants,
particularly unc-63, are severely uncoordinated (Culetto
et al., 2004; Fleming et al., 1997). Nonetheless, our results
demonstrate that nicotine-dependent behavior in C. ele-
gans requires nAChRs.
The Mouse nAChR a4b2 Can Functionally Substitute
for Worm nAChRs in Nicotine-Dependent Behavior
The essential role of nAChRs in nicotine-dependent be-
havior prompted us to explore the possibility that mam-
malian nAChRs may functionally substitute for C. elegans
nAChRs in this behavior. As the mouse a4b2 heteromeric
channel is the only nAChR that has thus far been found
to be essential and sufficient for mediating nicotine de-
pendence in mice (Champtiaux and Changeux, 2004;
Maskos et al., 2005; Tapper et al., 2004), we expressed
this mouse nAChR as a transgene in the acr-16 mutant
background under the acr-16 promoter. We found that
mouse a4b2 rescued the mutant phenotype in acute re-
sponse, withdrawal, and sensitization, though the trans-
gene did not significantly affect locomotion of wild-type
worms (Figure 3E; Figures S2A and S2B; data not shown).
Another mouse nAChR, a7, failed to rescue the mutant
phenotype (Figure 3E). While it is possible that such a neg-
ative result might simply stem from aberrant expression of
mouse a7 in worm cells, it is nonetheless noteworthy that
knockout studies in mice do not support an essential role
for a7 in nicotine dependence (Orr-Urtreger et al., 1997).
The observation that mammalian nAChRs can functionally
substitute for their C. elegans homolog in response to nic-
otine strongly suggests that at least some of the genes
regulating nicotine responses in mammals are functionally
conserved in C. elegans.
nAChRs Primarily Act in Neurons to Mediate
Nicotine-Dependent Behavior
Both neuron- and muscle-type nAChRs are present in
mammals; however, it is the neuronal, but not the muscu-lar, nAChRs that primarily mediate the psychostimulatory
effects of nicotine (Champtiaux and Changeux, 2004). We
therefore wondered whether this is also the case with C.
elegans nAChRs. However, acr-16 is not neuron specific,
has strong expression in muscle cells, and has been re-
ported to function as a nAChR in the neuromuscular junc-
tion (Ballivet et al., 1996; Francis et al., 2005; Touroutine
et al., 2005; Figure S3B). Similarly, acr-15 is also ex-
pressed in both neurons and muscles (Figure S3A). In
the nervous system, acr-15 can be found in interneurons
(including command interneurons), motor neurons, and
pharyngeal neurons (Figure S3A). We generated trans-
genic animals expressing ACR-15 specifically in neurons
or muscles in the acr-15 mutant background under a
neuron- or muscle-specific promoter, respectively. The
neuronal, but not the muscular, expression of ACR-15
rescued the nicotine defects in acr-15 mutant animals
including acute response, withdrawal, and sensitization
(Figure 4A and Figures S2A and S2B). Similar results
were also obtained with acr-16 (Figure 4A and Figures
S2A and S2B). It should be noted that nicotine can affect
muscle function under certain conditions. For example,
high concentrations of nicotine paralyze worms by acting
in the muscle (Gottschalk et al., 2005). Nevertheless, un-
der our conditions, nAChRs seem to primarily act in neu-
rons to mediate their function in nicotine responses.
Command Interneurons Are Important for Mediating
Nicotine Responses
Interestingly, expression of acr-15 under the glr-1 pro-
moter rescued the nicotine phenotype in acr-15 mutants
(Figure 4A). This promoter drives expression primarily in
command interneurons, the central players in the locomo-
tion circuitry, and a few other neurons (Hart et al., 1995;
Maricq et al., 1995), suggesting that acr-15 may act in
some of these neurons to mediate its function in nico-
tine-dependent behavior. The same promoter, however,
did not significantly rescue the acr-16 mutant phenotype
(Figure 4A), indicating the involvement of additional or dif-
ferent sets of neurons for acr-16 function in nicotine-
dependent behavior. Thus, we chose to focus on acr-15
for further characterization.
The observation that the glr-1 promoter-driven acr-15
rescued the mutant phenotype suggests that command
interneurons may be important for mediating nicotine-
dependent behavior. Therefore, we killed these neurons
(AVA, AVB, AVD, and PVC) with a laser. Worms lacking
PVC or AVD did not exhibit a significant defect in response
to nicotine incubation (Figure 4B). In contrast, ablation of
AVA rendered worms unresponsive to nicotine, demon-
strating an essential role for this neuron in nicotine-depen-
dent behavior (Figure 4B). Ablation of AVB also impaired
worms’ response to nicotine, though the ablated worms
retained residual nicotine response (Figure 4B). However,
unlike other command interneurons, AVB ablation makes
worms severely uncoordinated (Chalfie et al., 1985; data
not shown); thus, it remains possible that the observed
nicotine defects in these worms may result fromCell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc. 625
Figure 4. Nicotine Induces Calcium Re-
sponses in Command Interneurons that
Are Important for Nicotine-Dependent
Behavior
(A) Neuronal, but not muscular, expression of
acr-15 and acr-16 restored the acute response
to nicotine in naive acr-15(ok1214) and acr-
16(ok789) animals, respectively. The unc-119
andmyo-3 promoter was used to drive expres-
sion of acr-15 and acr-16 in neurons and mus-
cles, respectively. n R 10. *p < 0.04 (ANOVA
with Kruskal-Wallis H test).
(B) Worms lacking the command interneuron
AVA do not respond to nicotine incubation.
AVA, AVB, AVD, or PVC neurons were ablated
by laser microbeam. *p < 0.006 (ANOVA with
Kruskal-Wallis H test).
(C) Nicotine induces robust calcium responses
in the command interneuron AVA of live worms.
G-CaMP and DsRed2 were coexpressed as
a transgene under the nmr-1 promoter. AVA
was selected for imaging. Nicotine (100 mM)
was perfused toward the animal immobilized
on an agarose pad. The percentage change
of the ratio of G-CaMP/DsRed2 fluorescence
was plotted versus time. DsRed2 is insensitive
to calcium changes (Li et al., 2006). Shown is
a representative trace.
(D) Worms that were behaviorally adapted to
nicotine show little if any response to nicotine
in AVA. Worms that were treated with nicotine
overnight as described in Figure 1C were sub-
jected to imaging for nicotine-induced calcium
responses as described in (C).
(E) Nicotine-induced calcium responses are
potentiated in worms that were behaviorally
sensitized to nicotine. Worms that received
three doses of intermittent nicotine treatment
as described in Figure 2 were imaged for nico-
tine-induced calcium responses as described
in (C).
(F) ACR-15 is critical for nicotine-induced cal-
cium responses. The same G-CaMP transgene
was crossed into the acr-15 mutant back-
ground.
(G) Histogram of calcium imaging experiments.
The nicotine-induced calcium responses were greatly reduced in nicotine-adapted wild-type worms and naive acr-15worms (*p < 0.001, ANOVAwith
Dunnett test) but were potentiated in nicotine-sensitized wild-type worms (*p < 0.05, ANOVA with Dunnett test). nR 5. Error bars represent SEM.a nonspecific deficit in locomotion. As such, we decided
to focus on AVA for further characterization.
To provide physiological evidence that command inter-
neurons are important for nicotine responses, we re-
corded the activity of these neurons by calcium imaging
of live animals expressingG-CaMP, a genetically encoded
calcium sensor (Nakai et al., 2001). G-CaMP and camel-
eon have been successfully used in C. elegans to monitor
neuronal activity (Kahn-Kirby et al., 2004; Li et al., 2006;
Suzuki et al., 2003). DsRed was coinjected as a reference
marker, allowing for ratiometric imaging. We focused on
AVA because of its essential role in nicotine-dependent
behavior and its expression of ACR-15 (Figure 4A and
Figure S3A). In naive animals, acute nicotine perfusion eli-626 Cell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc.cited robust calcium responses in AVA (Figures 4C and
4G). In contrast, such responses were greatly reduced in
the animals that were behaviorally adapted to nicotine
by chronic nicotine treatment (Figures 4D and 4G), though
ACR-15 was upregulated in these animals (Figures S3C
and S3D). Chronic nicotine treatment also upregulates
nAChRs in mammals, the mechanism of which is not fully
understood (Marks et al., 1986). Notably, in the animals
that were behaviorally sensitized to nicotine, the nico-
tine-induced calcium responses were significantly poten-
tiated (Figures 4E and 4G). Importantly, very little response
to nicotine perfusion was observed in acr-15 mutant ani-
mals (Figures 4F and 4G), suggesting that ACR-15 is im-
portant for mediating the observed calcium responses.
In support of this in vivo observation, we found that, when
expressed in HEK293T cells, ACR-15 was capable of
forming a functional nAChR that can be activated by nico-
tine (Figure S4). Taken together, these results provide
a cellular andmolecular mechanism for nicotine regulation
of locomotion behavior and reveal a correlation between
behavioral responses and cellular physiology.
TRPC Channels Are Required for Nicotine-
Dependent Behavior
Having examined some genes known to regulate nicotine
responses,we then sought to identify novel genes involved
in the process. In an effort to characterize C. elegans
TRPC channels, we became intrigued by the possibility
that these channels might regulate nicotine-dependent
behavior. As a first step, we challenged wild-type animals
with 2-APB, a TRPC-channel inhibitor (Montell, 2005;
Ramsey et al., 2006), and found that this drug abolished
the response to acute nicotine treatment as well as to
nicotine withdrawal in wild-type animals, suggesting that
TRPC channels are required for nicotine-dependent
behavior (Figure 5A and Figure S5A). However, 2-APB
impinges on several other targets in addition to TRPC
channels (Montell, 2005; Ramsey et al., 2006). Therefore,
we decided to examine TRPC mutants.
The C. elegans genome encodes three TRPC-channel
homologs, TRP-1, TRP-2, and TRP-3 (Xu and Sternberg,
2003), all of which share the same domain structure with
human and fly TRPCs (Figure 5B). These include three or
four ankyrin repeats and a coiled-coil domain in the N ter-
minus followed by six putative transmembrane domains
and a TRP domain in the C-terminal cytoplasmic tail (Fig-
ure 5B). We isolated one trp-1 allele that deleted the pro-
moter region as well as the majority of the N terminus and
one trp-2 allele that ablated half of the transmembrane do-
mains (Figures 5C and 5D). Both alleles are likely to be null.
Both trp-1 and trp-2 mutant animals were superficially
wild-type (Figure S1 and data not shown), though some
moderate locomotion abnormalities can be detected
with our tracking system (Z.F. and X.Z.S.X., unpublished
data). Importantly, both trp mutants lacked response to
acute nicotine treatment, consistent with our pharmaco-
logical results (Figure 5E). As a result of this defect, these
mutants were also defective in nicotine withdrawal and
sensitization (Figures S5A and S5B). As a control, mutants
lacking the sperm-specific TRPC channel TRP-3, the
TRPV channel OSM-9, or the TRPM channel GTL-1 all re-
sponded normally to nicotine incubation (Colbert et al.,
1997; Teramoto et al., 2005; Xu and Sternberg, 2003)
(Figure 5E). Transgenic expression of wild-type copies of
the trp-2 gene in the trp-2 mutant background restored
mutant animals’ responses to nicotine including acute re-
sponse, withdrawal, and sensitization (Figure 5E and Fig-
ures S5A and S5B). Similar results were obtained with trp-
1 rescue (Figure 5E and Figures S5A and S5B). Therefore,
TRPC channels are required for nicotine-dependent be-
havior in C. elegans.TRP-1 has been reported to be expressed in multiple
classes of neurons, such as interneurons (including com-
mand interneurons), motor neurons, pharyngeal neurons,
and sensory neurons (Colbert et al., 1997). TRP-2 is also
expressed in these types of neurons (Figures S5D and
S5E). Expression of TRP-2 under the glr-1 promoter can
rescue the trp-2 mutant phenotype, including acute re-
sponse, withdrawal, and sensitization (Figure 5E and Fig-
ures S5A and S5B). Similar results were obtained for trp-1
(Figure 5E). This promoter was also able to rescue the acr-
15 mutant phenotype (Figure 4A), suggesting that TRPC
channels and ACR-15 might act in the same groups
of neurons or circuits to regulate nicotine-dependent
behavior.
TRP-2 Promotes Receptor-Operated Calcium Entry
In Vitro
We then asked whether worm TRPCs can function, like
their mammalian counterparts, as receptor-operated
channels (Montell, 2005; Ramsey et al., 2006). Although
the precise mechanisms leading to activation of mamma-
lian TRPCs remain uncertain, they all can be activated fol-
lowing the stimulation of phospholipase Cb (PLCb) when
expressed in heterologous systems (Montell, 2005; Ram-
sey et al., 2006). We used TRP-2 as an example and iso-
lated its cDNA by RT-PCR. Expression of TRP-2 in
HEK293T cells promoted receptor-operated calcium en-
try elicited by perfusion of carbachol (Figures 6A, 6B,
and 6G). Carbachol is known to induce such calcium entry
by stimulating PLCb via its endogenous receptors in
HEK293 cells that are coupled to heterotrimeric G proteins
(Montell, 2005; Ramsey et al., 2006). Further evidence
came from the observation that the TRP-2-dependent ac-
tivity in HEK293T cells can be blocked by U73122, a PLC
inhibitor (Figure 6H) (Montell, 2005; Ramsey et al., 2006).
As is the case with mammalian TRPCs, the TRP-2-depen-
dent activity in HEK293T cells was sensitive to 2-APB
(Figure 6H). In addition, TRP-2 appeared to be permeable
to Ba2+ and Sr2+, a feature shared by several mammalian
TRPCs (Figures 6C–6G) (Montell, 2005; Ramsey et al.,
2006). These observations provide strong evidence that
TRP-2 can function as a receptor-operated channel either
on its own or by interacting with endogenous TRP pro-
teins.
PLCb/EGL-8 Is Required for Nicotine-Dependent
Behavior
The requirement of PLCb for TRP-2 activation in vitro rai-
ses the possibility that PLCb may play a role in nicotine-
dependent behavior in vivo. egl-8 encodes the worm
PLCb homolog that is ubiquitously expressed in the ner-
vous system (Lackner et al., 1999; Miller et al., 1999).
egl-8 mutant animals did not exhibit significant response
to acute nicotine incubation or withdrawal (Figure 7A
and Figure S6A). We also examined the role of Gq/11 be-
cause this type of protein is known to function upstream of
PLCb (Montell, 2005). A reduction-of-function Gq/egl-30
mutant lacked response to nicotine incubation; however,Cell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc. 627
Figure 5. TRPC Channels Are Required for Nicotine-Dependent Behavior
(A) 2-APB blocks wild-type animals’ acute response to nicotine. Naive wild-type animals were assayed on nicotine plates with or without (control)
50 mM 2-APB. *p < 0.03 (Mann-Whitney U test).
(B) Sequence alignment of worm TRP-1 (cTRP-1), worm TRP-2 (cTRP-2), fly TRP (dTRP), and human TRPC3 (hTRPC3). The ankyrin repeats, coiled-
coil domain, six putative transmembrane domains, and TRP domain are indicated by the underlying dashed brackets, solid brackets, solid lines, and
double lines, respectively.
(C and D) Gene structure and mutations of trp-1 (C) and trp-2 (D). The positions of the trans-spliced leader sequence (SL1), the first Met, and the stop
codon are indicated. The underlying hollow rectangle indicates the fragment deleted in the trp-1(sy690) (C) and trp-2(sy691) (D) mutants.
(E) trp-1(sy690) and trp-2(sy691)mutant animals do not respond to acute nicotine treatment. Ex[Pglr-1::trp-2] and Ex[Pglr-1::trp-1] denote transgenes
expressing TRP-2 and TRP-1 under the glr-1 promoter, respectively. See Experimental Procedures for allele names. *p < 0.02 (ANOVA with Kruskal-
Wallis H test). nR 10. Error bars represent SD.628 Cell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc.
Figure 6. TRP-2 Promotes Receptor-
Operated Calcium Entry In Vitro
Shown are representative traces of mock-
transfected (A, C, and E) and TRP-2-trans-
fected (B, D, and F) cells.
(A and B) Expression of TRP-2 cDNA in human
HEK293T cells promotes receptor-operated
calcium entry. The initial calcium peak repre-
sents calcium release from internal calcium
stores. Subsequently, calcium was added to
the bath to reveal the activity of receptor-oper-
ated channels.
(C and D) TRP-2 is permeable to Ba2+.
(E and F) TRP-2 is permeable to Sr2+.
(G) Histogram of TRP-2-dependent activities in
HEK293T cells. The percentage ratio change
(D340/380 nm) per second during the first
30 s, but not the percentage peak ratio change,
was used to quantify receptor-operated chan-
nel activity because Ba2+ and Sr2+ responses
did not desensitize. Error bars represent SEM.
(H) TRP-2-dependent calcium activity in 293
cells is sensitive to 2-APB and U73122. The
control data (no drug) are duplicated from (G).
2-APB (100 mM) was applied right before cal-
cium reapplication, while U73122 (10 mM) was
added 10 min prior to carbachol perfusion.
nR 6. Error bars represent SEM.we cannot exclude the possibility that such a defect might
result from a nonspecific deficit in locomotion because
this mutant is severely uncoordinated (Brundage et al.,
1996; Miller et al., 1999). Nonetheless, our results demon-
strate an in vivo role for PLCb in regulating nicotine-
dependent behavior in C. elegans and are also consistent
with the role of TRPC channels in this behavior.
Human TRPC3 Can Functionally Substitute for
C. elegans TRP-2 in Nicotine-Dependent Behavior
In light of the functional similarity between TRP-2 and
mammalian TRPCs in heterologous systems, we rea-
soned that mammalian TRPCs might be able to substitute
for the function of TRP-2 in nicotine-dependent behavior
in C. elegans. To explore this possibility, we generated
transgenic animals expressing human TRPC genes in
the trp-2 mutant background under the trp-2 promoter.
Three human TRPC genes (hTRPC1, 3, and 4) were
tested, with each representing a subgroup of the human
TRPC subfamily (Montell, 2005; Ramsey et al., 2006).While negative results were obtained with hTRPC1 and
4, expression of hTRPC3 restored the responses of trp-2
mutant animals to nicotine, including acute response,
withdrawal, and sensitization (Figure 7A and Figure S6).
These results reveal functional conservation of TRPC
channels in regulating nicotine-dependent behavior.
TRPC Channels Are Important for Nicotine-Induced
Calcium Responses in Command Interneurons
The question arises as to how TRPC channels regulate
nicotine-dependent behavior. One possibility is that
nAChRs could depend on TRPC channels for their expres-
sion. However, this does not seem to be the case. For ex-
ample, TRP-2 was not required for ACR-15 expression
(Figure S3E and data not shown). As TRPCs and ACR-
15 may act in the same groups of neurons or circuits, we
tested whether TRPC channels can functionally regulate
nAChR activity by imaging nicotine-induced calcium
responses in live animals expressing the genetically
encoded calcium sensor G-CaMP. We found thatCell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc. 629
Figure 7. TRPC Channels Are Important
for Nicotine-Induced Calcium Re-
sponses in Command Interneurons
(A) Expression of human TRPC3 restores the
acute response to nicotine in trp-2(sy691) mu-
tant animals. hTRPC1, hTRPC3, and hTRPC4
cDNAs were expressed as transgenes (i.e.,
Ex[Ptrp-2::hTRPC1], Ex[Ptrp-2::hTRPC3], and
Ex[Ptrp-2::hTRPC4]) under the trp-2 promoter
in trp-2(sy691) mutant animals. n R 10. Error
bars represent SD. *p < 0.02 (ANOVA with
Kruskal-Wallis H test).
(B) Nicotine induces robust calcium responses
in the command interneuron AVA of live worms.
Nicotine (100 mM) was perfused toward the
animal immobilized on an agarose pad. The
percentage change of the ratio of G-CaMP/
DsRed2 fluorescence was plotted versus
time. A representative trace is shown.
(C and D) Nicotine-induced calcium responses
are greatly reduced in trp-2(sy691) (C) and trp-
1(sy690) (D) mutant worms. The same G-CaMP
transgene was crossed into the trp-2(sy691) or
trp-1(sy690) mutant background.
(E) Histogram of calcium imaging experiments.
The nicotine-induced calcium responses were
greatly reduced in trp-2(sy691) (*p < 0.003,
ANOVA with Dunnett test) and trp-1(sy690)
mutant worms (*p < 0.03, ANOVA with Dunnett
test). nR 8. Error bars represent SEM.nicotine-induced calcium responses in the command
interneuron AVA were greatly reduced in trp-2 and trp-1
mutant worms (Figures 7B–7E). Thus, it appears that
TRPC channels can functionally regulate nicotine-induced
neuronal activity in the locomotion circuitry, providing a
cellular mechanism for TRPC-channel regulation of nico-
tine-dependent behavior.
DISCUSSION
C. elegans Can Be Used as a Genetic Model to
Characterize Genes Regulating Nicotine Responses
In the current study, we developed a C. elegans model of
nicotine-dependent behavior. Our results indicate that
C. elegans displays several types of behavioral responses
to nicotine that parallel those observed in vertebrates.
These include acute response, tolerance, withdrawal,
and sensitization. In addition, we show that nicotine re-
sponses in C. elegans require nAChRs, the molecular tar-
gets of nicotine that are known tomediate nicotine depen-
dence in mammals (Champtiaux and Changeux, 2004;
Laviolette and van der Kooy, 2004). These results demon-
strate that at least some of the genes regulating nicotine
responses inmammals are functionally conserved inC. el-
egans and suggest thatC. elegans is a valuable system for
characterizing genes regulating nicotine responses.
While only 17 nAChR genes are present in mammals,
the C. elegans genome encodes 28 such genes. Among630 Cell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc.the worm nAChR genes that have been examined for ex-
pression patterns, all have been found to be expressed
in neurons (Jones and Sattelle, 2004). Although much is
known about the role of these nAChRs in regulating mus-
cle activity (Francis et al., 2005; Gottschalk et al., 2005;
Richmond and Jorgensen, 1999; Touroutine et al., 2005;
Waggoner et al., 2000), their functions in the nervous sys-
tem are not well understood. We have shown that at least
two nAChR genes, acr-15 and acr-16, are required for nic-
otine-dependent behavior. Both nAChRs can be activated
by nicotine when expressed in heterologous systems
(Figure S4; Ballivet et al., 1996). Although these two
nAChRs are expressed in both neurons and muscles, as
is the case with their mammalian counterparts, we have
found that under our conditions, they primarily act in neu-
rons to regulate nicotine-dependent behavior. One site of
action for ACR-15 seems to be in the command interneu-
rons. Nevertheless, it remains unclear in which neurons
ACR-16 acts to mediate its function in nicotine responses.
Nicotine dependence in mammals is a highly complex
phenomenon entailing the function and coordination of
multiple nAChR genes and brain regions. In worms, it
may also involve the action of multiple nAChRs expressed
in different classes of neurons that are directly or indirectly
connected to the locomotion circuitry.
Our laser ablation and calcium imaging experiments
suggest that command interneurons are important for
nicotine-dependent behavior. This is consistent with the
critical role of these neurons in locomotion (Chalfie and
White, 1988). Nevertheless, our results do not exclude
the involvement of other types of neurons in regulating
nicotine-dependent behavior. Among the four major pairs
of command interneurons, AVA neurons are essential for
nicotine-dependent behavior; AVB neurons may also
play an important role. One function for AVA neurons is
to regulate spontaneous reversal frequency during loco-
motion (Chalfie et al., 1985; Zheng et al., 1999). However,
these neurons also receive synaptic input from, as well as
synapse onto, other command interneurons including
AVB and PVC, both of which are known to regulate for-
ward movement (Chalfie et al., 1985; White et al., 1986).
Upon nicotine stimulation, AVA and AVB may tune the ac-
tivity of the locomotion circuitry, leading to the observed
behavioral effects.
TRPC Channels Are Important for Nicotine-
Dependent Behavior
We have also begun to identify proteins that were not pre-
viously known to regulate nicotine-dependent behavior
and have found that TRPC channels are required for this
behavior in C. elegans. Specifically, trp mutant worms
are defective in the acute nicotine response, which might
lead to defects of these mutants in other nicotine re-
sponses such as nicotine withdrawal and sensitization.
The role of TRPC channels in nicotine responses is also
supported by the observation that PLCb, a protein impor-
tant for TRPC-channel activation, is critical for nicotine-
dependent behavior in C. elegans.
How do TRPC channels regulate nicotine-dependent
behavior? Our rescue experiments suggest that TRPC
channels and the nAChR ACR-15 may act in the same
groups of neurons or circuits to mediate their function in
nicotine responses. Indeed, worms lacking TRPC chan-
nels are defective in nicotine-induced, ACR-15-depen-
dent calcium responses in some command interneurons.
Thus, while other mechanisms may also contribute, one
mechanism by which TRPC channels regulate nicotine-
dependent behavior appears to be through functionally
modulating nicotine-induced command interneuron activ-
ity in the locomotion circuitry. TRPC channels may do so
by acting directly in command interneurons and/or indi-
rectly via network activity.
All six human TRPC channels are expressed in the cen-
tral nervous system (CNS) (Montell, 2005; Ramsey et al.,
2006). Despite extensive in vitro studies in cell culture sys-
tems implicating mammalian TRPC channels in various
neuronal activities in the CNS, such as synaptic transmis-
sion, growth-cone guidance and morphology, and neurite
extension (reviewed in Ramsey et al., 2006), the genetic
evidence supporting such roles for these channels is still
lacking. Our studies identify an unexpected role for TRPCs
in nervous-system function and reveal a functional link be-
tween TRP-family channels and nicotinic signaling. The
observation that a human TRPC homolog can functionally
substitute for a C. elegans TRPC channel also raises the
possibility that these channels might regulate nicotinedependence and perhaps other types of substance
dependence in mammals.
EXPERIMENTAL PROCEDURES
Genetics and Molecular Biology
The following mutant alleles were used in the study: acr-5(ok180),
acr-8(ok1240), acr-9(ok933), acr-11(ok1345), acr-12(ok367), acr-
14(ok1155), acr-15(ok1214), acr-16(ok789), acr-18(ok1285), acr-
19(ok967), acr-21(ok1314), deg-2(u695)deg-3(u662), deg-3(tu1851),
eat-2(ad465), eat-4(ky5), egl-8(n488), egl-30(md186), gtl-1(ok375),
lev-1(e211), lev-8(x15), osm-9(ky10), trp-1(sy690), trp-2(sy691), trp-
3(sy693), unc-29(x29), unc-38 (x20), and unc-63(x13).
To generate the unc-119 promoter-driven transgenic lines, the unc-
119 promoter was amplified by PCR from a plasmid (PBY103), fused
by PCR with a PCR fragment (amplified from genomic DNA) encoding
the coding region of acr-15 and acr-16, and injected into the acr-
15(ok1214) and acr-16(ok789) mutant background, respectively.
Transgenic lines expressing the myo-3 and glr-1 promoter-driven
transgenes were generated with the same strategy. The myo-3 pro-
moter and glr-1 promoter were amplified by PCR from pPD136.64
(a gift from A. Fire) and genomic DNA, respectively (Hart et al., 1995;
Maricq et al., 1995). To make transgenic worms expressing the trans-
gene Pacr-16::mousea4b2, the acr-16 promoter (6 kb) was amplified
by PCR from genomic DNA; fused by PCR with a PCR fragment of the
mouse a4 cDNA or b2 cDNA coding region linked to the unc-54 30UTR,
respectively; and coinjected at a ratio of 2:3 into the acr-16(ok789)mu-
tant background. To generate transgenic lines expressing Ptrp-2::
hTRPC3, the trp-2 promoter (3.5 kb) was amplified from the cosmid
R06B10, fused by PCR with a PCR fragment of human TRPC3 cDNA
coding region linked to the unc-54 30UTR, and directly injected into
the trp-2(sy691) mutant background. The Ptrp-2::hTRPC1 and Ptrp-
2::hTRPC4 transgenes were constructed with the same strategy. The
cosmids ZC21 and R06B10 were used to rescue the trp-1(sy690)
and trp-2(sy691)mutants, respectively. At least two independent lines
were analyzed for each transgene. Both trp alleles were backcrossed
to N2 seven times before behavioral analysis.
Cell Culture and Calcium Imaging
Cell culture and calcium imaging were performed as previously de-
scribed (Li et al., 2006; Xu and Sternberg, 2003). See details in Supple-
mental Data.
Behavioral Analysis
L4 hermaphrodites were picked 16 hr before behavioral analysis. The
NGM plates used for tracking were freshly spread with a thin layer of
E. coli OP50 5 min prior to tracking. Tracking was performed at
20C–21C and a relative humidity of 40% with the lid off. The track-
ing system consists of a stereomicroscope (Zeiss Stemi 2000C)
mounted with a digital camera (Cohu 7800), a digital motion system
(Parker Automation) that follows worm movement, and a home-devel-
oped software package. To record locomotion, animals’ images were
grabbed at a rate of 2 Hz for 16 min. The locomotion velocity of the an-
imal at each time point, computed as centroid displacement (mm) per
second, was plotted and displayed in real time during tracking. The
vision/motion data were also compressed, integrated, and stored as
a commonly used multimedia file format (AVI). Nicotine was included
in media right before plates were poured. DHbE and 2-APB were di-
rectly spread on the surface of NGM plates and allowed to diffuse
for >16 hr prior to use. Animals were preincubated with DHbE for
1 hr prior to analyzing their response to nicotine.
Behavioral Quantification
Methods for quantifying locomotion-stimulation are described in the
Supplemental Data.Cell 127, 621–633, November 3, 2006 ª2006 Elsevier Inc. 631
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, and six figures can be foundwith this article
online at http://www.cell.com/cgi/content/full/127/3/621/DC1/.
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